Liu Xiao spends her weeks visiting sludge and organic waste treatment plants across China. The travel can be tiring but as a technical and policy adviser on waste management she must help implement President
The European Commission wants European Union member states to issue new rules protecting conventional and organic farming from farmers using genetically modified crops. The proposal, contained in a
Portugal fears a European Union ban on its chicken exports after an illegal drug that can increase the risk of cancer in humans was found in animals at 43 farms. Armando Sevinate Pinto, Portugal's
Iressa was supposed to be the dream drug for advanced lung cancer patients and its developer, AstraZeneca. Known as a molecular targeting drug, which pinpoints and attacks cancer cells, Iressa
Daily doses of aspirin protect against colon cancer, say two reports in New England Journal of Medicine (NEJM), raising the possibility that the drug could one day be widely used as a biological
The US Supreme Court spoke out against abusive asbestos litigation but ruled by a narrow majority that courts should resist the temptation to rewrite liability rules just to tackle the crisis over
A leading Chinese rural affairs specialist has warned that the country must take into account regional economic disparities as it implements legislation making it easier for farmers to sell land they
The US pharmaceuticals industry has nothing to fear from a deal over patient protection on drugs in the developing world, according to one of Indian's leading manufacturers of generic medicines.
The European Union's much-trumpeted Everything But Arms (EBA) policy, which provides duty-free access for imports from the world's poorest nations, has failed to so far to benefit the countries it is
A patent protecting Zyprexa, a schizophrenia treatment that is Eli Lilly's biggest selling drug, is under greater than expected risk from a court challenge by a generic competitor, according to new
Indian rules on pharmaceuticals testing are to be brought into line with standards in mature economies in a reform that should encourage foreign drug companies and overseas researchers to step up
